Syros Pharmaceuticals (NASDAQ:SYRS) reported its Q4 earnings results on Tuesday, March 15, 2022 at 07:30 AM.
Here's what investors need to know about the announcement.
Earnings
Syros Pharmaceuticals beat estimated earnings by 19.15%, reporting an EPS of $-0.38 versus an estimate of $-0.47.
Revenue was up $2.10 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.03 which was followed by a 3.17% increase in the share price the next day.
Here's a look at Syros Pharmaceuticals's past performance:
| Quarter | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 |
|---|---|---|---|---|
| EPS Estimate | -0.44 | -0.37 | -0.46 | -0.50 |
| EPS Actual | -0.41 | -0.36 | -0.23 | -0.62 |
| Revenue Estimate | 4.49M | 4.13M | 2.67M | 2.70M |
| Revenue Actual | 5.70M | 5.16M | 4.83M | 5.70M |
To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
